Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Jump to content

Talk:Low-dose naltrexone

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:WikiProject iconMedicine Low‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
LowThis article has been rated as Low-importance on the project's importance scale.
WikiProject iconPharmacology C‑class Low‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
CThis article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
LowThis article has been rated as Low-importance on the project's importance scale.

add this reference[edit]

please consider adding this reference to the article: Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313374/ 2018.

(I could do it by myself, but I am not experienced in editing wikipedia articles) MarianIvelky (talk) 11:51, 5 June 2024 (UTC)[reply]

Hi Marian, I've added a brief paragraph on this review to the Research section of the article. Cheers, Ethmostigmus 🌿 (talk | contribs) 08:48, 6 June 2024 (UTC)[reply]